Evaluation of adrenal masses in lung cancer patients using F-18 FDG PET/CT

被引：14

作者：

Cho A.R. ^{[1
]}

Lim I. ^{[1
,2
]}

Na I.I. ^{[3
]}

Choe D.H. ^{[4
]}

Park J.Y. ^{[1
]}

Kim B.I. ^{[1
,2
]}

Cheon G.J. ^{[1
,2
]}

Choi C.W. ^{[1
,2
]}

Lim S.M. ^{[1
,2
]}

机构：

[1] Department of Nuclear Medicine, Korea Institute of Radiological and Medical Sciences, Gongneung-Dong, Nowon-Gu, Seoul 139-706

[2] Molecular Imaging Research Center, Korea Institute of Radiological and Medical Sciences, Seoul

[3] Department of Internal Medicine, Korea Institute of Radiological and Medical Sciences, Seoul

[4] Department of Radiology, Korea Institute of Radiological and Medical Sciences, Seoul

来源：

Nuclear Medicine and Molecular Imaging | 2011年 / 45卷 / 1期

关键词：

Adrenal metastasis; FDG; Lung cancer; PET/CT;

D O I：

10.1007/s13139-010-0064-6

中图分类号：

学科分类号：

摘要：

Purpose: The aim of this study was to assess the diagnostic efficacy of PET/CT using various parameters for the characterization of adrenal nodules in lung cancer patients. Methods: Sixty-one adrenal nodules in 51 lung cancer patients were evaluated. The final diagnosis was based on histology (n=2) or imaging follow-up (n=59, range of follow-up: 7-57 months, median 27 months). Each adrenal nodule was analyzed using four parameters of PET/CT: the maximum standardized uptake value (SUVmax), the adrenal nodule/liver ratio of the SUV (SUV ratio), Hounsfield units (HU) and size. The optimal cutoff of each parameter for the identification of metastatic nodule was determined by ROC analysis and then the diagnostic efficacy was compared among the parameters. Results: Of the 61 adrenal nodules, 45 (73%) were considered metastasis. The optimal cutoff values of the parameters were SUVmax >2.7, SUV ratio >1.3, HU >18 and size>20 mm, respectively. The sensitivity, specificity and accuracy by SUVmax >2.7 were 88.9%, 87.5% and 88.5%, and those by SUV ratio >1.3 were 84.4%, 100% and 88.5%, respectively. The combination of SUV ratio >1.3 and HU >18 had sensitivity of 97.7%, specificity of 81.2% and accuracy of 93.4% to predict adrenal metastasis in patients with lung cancer. Conclusion SUV ratio from F-18 FDG PET/CT could identify the adrenal metastasis in lung cancer patients. The combination of SUV ratio and HU can improve the accuracy of differentiating benign and metastatic adrenal lesions in lung cancer patients. © Korean Society of Nuclear Medicine 2010.

引用

页码：52 / 58

页数：6

共 25 条

[1]

Kloos R.T., Gross M.D., Francis I.R., Korobkin M., Shaprio B., Incidentally discovered adrenal masses, Endocr Rev., 16, pp. 460-484, (1995)

[2]

Mansmann G., Lau J., Balk E., Rothberg M., Miyachi Y., Bornstein S.R., The clinically inapparent adrenal mass: update in diagnosis and management, Endocr Rev., 25, pp. 309-340, (2004)

[3]

Abrams H.L., Siro R., Goldstein N., Metastases in carcinoma: analysis of 1, 000 autopsied cases, Cancer, 3, pp. 74-85, (1950)

[4]

Mody M.K., Kazerooni E.A., Korobkin M., Percutaneous CT-guided biopsy of adrenal masses: immediate and delayed complications, J Comput Assist Tomogr., 19, pp. 434-439, (1995)

[5]

Boland G.W., Lee M.J., Gazelle G.S., Halpern E.F., McNicholas M.M., Mueller P.R., Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature, AJR Am J Roentgenol., 171, pp. 201-204, (1998)

[6]

Lee M.J., Hahn P.F., Papanicolaou N., Egglin T.K., Saini S., Mueller P.R., Et al., Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis, Radiology, 179, pp. 415-418, (1991)

[7]

Korobkin M., Giordano T., Brodeur F., Francis I.R., Siegelman E.S., Quint L.E., Et al., Adrenal adenomas: relationship between histologic lipid and CT and MR findings, Radiology, 200, pp. 743-747, (1996)

[8]

Haider M.A., Ghai S., Jhaveri K., Lockwood G., Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?, Radiology, 231, pp. 711-716, (2004)

[9]

Reinig J.W., Doppman J.L., Dwyer A.J., Frank J., MRI of indeterminate adrenal masses, AJR Am J Roentgenol., 147, pp. 493-496, (1986)

[10]

Kumar R., Xiu Y., Yu J.Q., Takalkar A., El-Haddad G., Potenta S., Et al., <sup>18</sup>F-FDG PET in evaluation of adrenal lesions in patients with lung cancer, J Nucl Med., 45, pp. 2058-2062, (2004)

← 1 2 3 →